<i>DRD4</i> Exon 3 Gene Polymorphisms in Patients Diagnosed with Polysubstance Use Disorder and Co-Occurrence of a Depressive Episode
Background: There has been a noticeable and systematic growth of the use of psychoactive substances over the past few decades. Dual diagnosis is a clinical term referring to the occurrence of psychoactive substance use disorder comorbid with another psychiatric disorder in the same person. The most...
Main Authors: | Krzysztof Chmielowiec, Jolanta Chmielowiec, Jolanta Masiak, Małgorzata Czekaj, Piotr Krawczyk, Ewelina Soroka, Małgorzata Śmiarowska, Wojciech Musiał, Tomasz Pawłowski, Anna Grzywacz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/11/1834 |
Similar Items
-
<i>DRD4, DRD2, DAT1,</i> and <i>ANKK1</i> Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions
by: Jolanta Masiak, et al.
Published: (2020-11-01) -
Analysis of Selected Variants of <i>DRD2</i> and <i>ANKK1</i> Genes in Combat Athletes
by: Monika Michałowska-Sawczyn, et al.
Published: (2021-08-01) -
Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder
by: Aleksandra Suchanecka, et al.
Published: (2020-04-01) -
Associations between the <i>COMT</i> rs4680 Gene Polymorphism and Personality Dimensions and Anxiety in Patients with a Diagnosis of Other Stimulants Dependence
by: Krzysztof Chmielowiec, et al.
Published: (2022-09-01) -
Analysis of Relationships between <i>DAT1</i> Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
by: Jolanta Chmielowiec, et al.
Published: (2021-12-01)